| The growth determinants and transport properties of tunneling nanotube networks between B lymphocytes A Osteikoetxea-Molnár, E Szabó-Meleg, EA Tóth, Á Oszvald, E Izsépi, ... Cellular and Molecular Life Sciences 73, 4531-4545, 2016 | 65 | 2016 |
| Dynamic control of RSK complexes by phosphoswitch‐based regulation G Gógl, B Biri‐Kovács, ÁL Póti, H Vadászi, B Szeder, A Bodor, ... The FEBS journal 285 (1), 46-71, 2018 | 37 | 2018 |
| Body fatness and endogenous sex hormones in the menopausal transition A Zsakai, Z Karkus, K Utczas, B Biri, LL Sievert, EB Bodzsar Maturitas 87, 18-26, 2016 | 34 | 2016 |
| In Vivo Tumor Growth Inhibition and Antiangiogenic Effect of Cyclic NGR Peptide-Daunorubicin Conjugates Developed for Targeted Drug Delivery AAP Tripodi, I Ranđelović, B Biri-Kovács, B Szeder, G Mező, J Tóvári Pathology & Oncology Research 26, 1879-1892, 2020 | 30 | 2020 |
| Cellular internalization and inhibition capacity of new anti-glioma peptide conjugates: physicochemical characterization and evaluation on various monolayer-and 3D-spheroid … Z Baranyai, B Biri-Kovács, M Kratky, B Szeder, ML Debreczeni, J Budai, ... Journal of medicinal chemistry 64 (6), 2982-3005, 2021 | 29 | 2021 |
| Rewiring of RSK–PDZ interactome by linear motif phosphorylation G Gógl, B Biri-Kovács, F Durbesson, P Jane, Y Nomine, C Kostmann, ... Journal of molecular biology 431 (6), 1234-1249, 2019 | 29 | 2019 |
| Enhanced in vitro antitumor activity of GnRH-III-daunorubicin bioconjugates influenced by sequence modification S Schuster, B Biri-Kovács, B Szeder, L Buday, J Gardi, Z Szabó, ... Pharmaceutics 10 (4), 223, 2018 | 29 | 2018 |
| Synthesis and in vitro biochemical evaluation of oxime bond-linked daunorubicin–GnRH-III conjugates developed for targeted drug delivery S Schuster, B Biri-Kovács, B Szeder, V Farkas, L Buday, Z Szabó, ... Beilstein Journal of Organic Chemistry 14 (1), 756-771, 2018 | 27 | 2018 |
| Ezrin interacts with S100A4 via both its N-and C-terminal domains B Biri-Kovács, B Kiss, H Vadászi, G Gógl, G Pálfy, G Török, L Homolya, ... PloS one 12 (5), e0177489, 2017 | 25 | 2017 |
| Structure–activity relationship of HER2 receptor targeting peptide and its derivatives in targeted tumor therapy B Biri-Kovács, A Adorján, I Szabó, B Szeder, S Bősze, G Mező Biomolecules 10 (2), 183, 2020 | 23 | 2020 |
| Metastasis-associated S100A4 is a specific amine donor and an activity-independent binding partner of transglutaminase-2 B Biri, B Kiss, R Király, G Schlosser, O Láng, L Kőhidai, L Fésüs, L Nyitray Biochemical Journal 473 (1), 31-42, 2016 | 23 | 2016 |
| Sequence modification of heptapeptide selected by phage display as homing device for HT-29 colon cancer cells to improve the anti-tumour activity of drug delivery systems K Kiss, B Biri-Kovács, R Szabó, I Ranđelović, KN Enyedi, G Schlosser, ... European Journal of Medicinal Chemistry 176, 105-116, 2019 | 22 | 2019 |
| Novel Assay Platform to Evaluate Intracellular Killing of Mycobacterium tuberculosis: In Vitro and In Vivo Validation K Horváti, K Fodor, B Pályi, J Henczkó, G Balka, G Gyulai, É Kiss, ... Frontiers in Immunology 12, 750496, 2021 | 17 | 2021 |
| Non-blocking modulation contributes to sodium channel inhibition by a covalently attached photoreactive riluzole analog P Lukacs, MC Földi, L Valánszki, E Casanova, B Biri-Kovács, L Nyitray, ... Scientific Reports 8 (1), 8110, 2018 | 15 | 2018 |
| Comparative cell biological study of in vitro antitumor and antimetastatic activity on melanoma cells of GnRH-III-containing conjugates modified with short-chain fatty acids E Lajkó, S Spring, R Hegedüs, B Biri-Kovács, S Ingebrandt, G Mező, ... Beilstein Journal of Organic Chemistry 14 (1), 2495-2509, 2018 | 14 | 2018 |
| TXNL1 has dual functions as a redox active thioredoxin-like protein as well as an ATP-and redox-independent chaperone A Andor, M Mohanraj, ZA Pató, K Úri, B Biri-Kovács, Q Cheng, ESJ Arnér Redox Biology 67, 102897, 2023 | 11 | 2023 |
| Host cell targeting of novel antimycobacterial 4-aminosalicylic acid derivatives with tuftsin carrier peptides LB Horváth, M Krátký, V Pflégr, E Méhes, G Gyulai, G Kohut, Á Babiczky, ... European Journal of Pharmaceutics and Biopharmaceutics 174, 111-130, 2022 | 11 | 2022 |
| Targeting the gastrin-releasing peptide receptor (GRP-R) in cancer therapy: Development of bombesin-based peptide–drug conjugates J Gomena, B Vári, R Oláh-Szabó, B Biri-Kovács, S Bősze, A Borbély, ... International Journal of Molecular Sciences 24 (4), 3400, 2023 | 10 | 2023 |
| Peptide vaccines in melanoma: chemical approaches towards improved immunotherapeutic efficacy B Biri-Kovács, Z Bánóczi, A Tummalapally, I Szabó Pharmaceutics 15 (2), 452, 2023 | 10 | 2023 |
| Old polyanionic drug suramin suppresses detrimental cytotoxicity of the host defense peptide LL-37 M Quemé-Peña, M Ricci, T Juhász, K Horváti, S Bősze, B Biri-Kovács, ... ACS Pharmacology & Translational Science 4 (1), 155-167, 2020 | 10 | 2020 |
